Athersys Investor Relations Material
Latest events
Investor Update
Athersys
Q3 2023
16 Nov, 2023
Investor Presentation
24 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Athersys Inc
Access all reports
Athersys Inc is a biotechnology company focused on the research and development of regenerative medicine therapies. Its lead programs involve cell-based therapies for treating neurological conditions, inflammatory diseases, and cardiovascular indications. The company is headquartered in Cleveland, Ohio, and its shares are listed on the NASDAQ.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
ATHX
Country
🇺🇸 United States